Growth Metrics

Palvella Therapeutics (PVLA) EPS (Basic) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -62.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -62.16%
Dec 31, 2025 -1,000.00%
Sep 30, 2025 73.86%
Jun 30, 2025 65.18%
Mar 31, 2025 51.95%
Dec 31, 2024 -99.42%
Sep 30, 2024 54.71%
Jun 30, 2024 -168.04%
Mar 31, 2024 89.12%
Sep 30, 2023 -6,592.31%
Jun 30, 2023 2,692.86%
Mar 31, 2023 -20,114.29%
Sep 30, 2022 45.83%
Jun 30, 2022 44.00%
Mar 31, 2022 0.00%
Dec 31, 2021 50.00%
Sep 30, 2021 7.69%
Jun 30, 2021 -177.78%
Mar 31, 2021 0.00%
Dec 31, 2020 -333.33%
Sep 30, 2020 -420.00%
Jun 30, 2020 62.50%
Mar 31, 2020 65.00%
Dec 31, 2019 71.43%
Sep 30, 2019 54.55%
Jun 30, 2019 -6,282.23%
Mar 31, 2019 -17.65%
Dec 31, 2018 -216.67%
Sep 30, 2018 31.25%
Jun 30, 2018 98.37%
Mar 31, 2018 10.53%
Dec 31, 2017 212.50%
Sep 30, 2017 -14.29%
Jun 30, 2017 -64.29%
Mar 31, 2017 -90.00%
Dec 31, 2016 -128.57%
Sep 30, 2016 -40.00%
Jun 30, 2016 -16.67%
Mar 31, 2016 23.08%
Sep 30, 2015 41.18%
Jun 30, 2015 50.00%
Mar 31, 2015 -85.71%
Sep 30, 2014 -17,897.22%
Jun 30, 2014 -437,856.20%